Management Quality -- 7/10
BUD scores a 7 on management quality. Michel Doukeris has proven to be a disciplined, strategic
operator who inherited a leveraged, acquisition-dependent company and is successfully transforming
it into an organic growth compounder. Financial delivery has been remarkably consistent -- 13+
quarters of EBITDA within or above the 4-8% range, 220bps of margin expansion in two years,
a step-change in FCF, and deleveraging from ~4x to sub-3x. The US turnaround after the Bud Light
crisis was strategically sound. Deductions come from persistent global volume declines (-1.5%,
-2.5% in FY24/25), China execution lagging industry for 6+ quarters, and organic EBITDA growth
deceleration through 2025.
Weight: 20%
CEO
Michel Doukeris (since July 2021)
ABI lifer since 1996 via AmBev | CFO Fernando Tennenbaum
Promise Delivery
7/11 MET, 2 On Track, 2 Not Met
EBITDA range, buybacks, dividends, BEES all delivered; volume and China lagging
Deleveraging
~4x to 2.87x Net Debt/EBITDA
Sub-3x for first time since 2015 | Long-term target 2x
Capital Returns
$6B Buyback + Progressive Dividend
$2B program completed, escalated to $6B | Dividend +15% YoY in FY25
Leadership team
Michel Doukeris -- CEO (since July 2021)
Career ABI lifer who joined in 1996 via AmBev. Former North America zone president.
Architect of the strategic pivot from inorganic to organic growth. Introduced 3-pillar
strategy: Lead & Grow Category, Digitize/Monetize Ecosystem, Optimize Business.
Communication style is repetitive by design, highly structured, and relentlessly on-message.
Rarely makes specific numerical promises beyond the 4-8% EBITDA range. Avoids forward
volume guidance entirely.
Fernando Tennenbaum -- CFO
Steady partner to Doukeris, disciplined on capital allocation messaging. Together they
have executed the deleveraging from ~4x to sub-3x while simultaneously increasing buybacks
($1B to $2B to $6B), introducing progressive dividends, and maintaining $7B+ annual
sales and marketing spend. Provides consistent framework for investment versus returns.
Promise tracking (11 promises)
| # | Promise | When | Target | Actual Result | Verdict |
|---|---|---|---|---|---|
| 1 | Medium-term organic EBITDA growth of 4-8% | Q4 2021 | Rolling annual 4-8% organic EBITDA growth | FY2024: +8.1% (top of range). FY2025: +4.9% (within range). 13+ consecutive quarters within or above range. | MET |
| 2 | Raised FY2024 EBITDA outlook to 6-8% | Q3 2024 | FY2024 organic EBITDA growth 6-8% | FY2024 organic EBITDA growth was ~8.1%, at top of raised outlook. | MET |
| 3 | US portfolio reaching inflection point | Q4 2024 | Build momentum in US portfolio | Michelob Ultra became #1 volume brand in US by mid-2025. Busch Light #2 share gainer. Portfolio gained volume share 5+ consecutive quarters. | MET |
| 4 | Bud Light crisis / US volume recovery | Post-Apr 2023 | Manage through boycott, recover volumes | NA organic volumes still negative (-12.4k hl FY23, -3.4k hl FY24, -2.6k hl FY25). Losses narrowed but never turned positive. Pivoted to portfolio rebalancing. | PARTIAL |
| 5 | Deleveraging to ~2x net debt/EBITDA | 2021 onward | Long-term optimal structure at 2x | Reached 2.89x at FY2024, 2.87x at FY2025. First time below 3x since 2015. Strong progress from ~4x post-SABMiller. | ON TRACK |
| 6 | $2B share buyback program | Q3 2024 | Complete $2B buyback in 12 months | Completed by mid-2025. Then announced $6B buyback (24 months) in Q3 2025. Escalated returns. | MET |
| 7 | Progressive dividend over time | Q4 2024 | Grow dividend progressively | FY2024 dividend EUR 1/share (+22% YoY). FY2025 total dividend +15% YoY. First interim dividend since 2019. | MET |
| 8 | Free cash flow step-change | Q4 2024 | Improve FCF structurally | $11.3B FCF in FY2024 (+$2.5B YoY). Continued improvement in 2025 via lower interest, efficient CapEx, working capital. | MET |
| 9 | BEES Marketplace scaling | 2021 strategy | Scale digital marketplace | GMV: $1.6B (2023) to $2.5B (2024, +57%) to $3.5B (2025, +61%). $53B total GMV, 75% of revenue digitized. | MET |
| 10 | China: confident in long-term, reignite growth | Q3 2024 | Reignite growth in China market | Revenue declined ~16% Q3 2024, ~6% Q2 2025, low-teens FY2025. Underperformed industry 6+ quarters. Share stabilized flat YoY by Q4 2025. | NOT MET |
| 11 | Volume growth aspiration (global) | 2025 calls | Grow global volumes organically | FY2024 volumes -1.5%; FY2025 volumes -2.5%. Two consecutive years of decline. Offset by pricing/mix/productivity. | NOT MET |
11 promises tracked. 7 MET (EBITDA range, raised outlook, US portfolio, buybacks, dividend, FCF, BEES),
1 ON TRACK (deleveraging), 1 PARTIAL (Bud Light -- shrewd pivot but NA volumes still negative),
2 NOT MET (China underperformance and global volume declines). The financial delivery is excellent;
the volume story is the clear weak spot.
Source: Earnings call transcripts Q3 2024 through Q4 2025, Daloopa.
Qualitative strengths
Exceptional Financial Discipline
Delivered EBITDA within 4-8% range for 13+ consecutive quarters despite volume headwinds,
China weakness, the Bud Light crisis, and FX headwinds. This is a hallmark of a well-run
operation and one of the most consistent delivery records in global consumer staples.
Shrewd US Crisis Management
Rather than panic-investing to restore Bud Light specifically, Doukeris pivoted to portfolio
rebalancing -- accelerating Michelob Ultra, Busch Light, Cutwater, and NUTRL. This was the
right strategic call. US share has been gaining for 5+ consecutive quarters. Michelob Ultra
became the #1 volume brand in the US.
Capital Allocation Evolution
Deleveraged from ~4x to sub-3x while simultaneously increasing buybacks ($1B to $2B to $6B),
introducing progressive dividends (+22% then +15% YoY), and maintaining $7B+ annual S&M
spend. Textbook capital allocation discipline with increasing flexibility.
Margin Execution
EBITDA margin expanded from 33.6% (2023) to 35.1% (2024) to 35.8% (2025) -- +220bps in two
years despite negative volumes and FX headwinds. The premiumization plus cost discipline
flywheel is working. Demonstrates pricing power and operational efficiency.
BEES Digital Platform is Real
Not vaporware. $53B GMV, 75% of revenue digitized, marketplace at $3.5B and growing 60%+.
3P model accelerating. This is a genuine structural advantage that creates distribution
moat and data-driven insights across the global supply chain.
Communication Consistency
Doukeris and Tennenbaum are extraordinarily disciplined in messaging. No hype, no panic.
They set a framework (4-8% EBITDA), explain the strategy, and deliver. Repetitive by design.
Best-in-class communication for the global consumer staples sector.
Red flags assessment
| Red Flag | Status | Detail |
|---|---|---|
| CEO/C-suite turnover | NO | Doukeris stable since 2021. Tennenbaum stable as CFO. No churn. |
| Missed guidance | NO | EBITDA within 4-8% range every year since framework introduced. |
| Aggressive accounting | LOW RISK | Normalized EBITDA is standard for the industry. Argentina organic growth cap (26.8%) was transparently disclosed. |
| Related-party transactions | NO | None flagged in transcripts or filings. |
| Insider selling / misaligned incentives | NO | Buybacks signal alignment. 3G Capital has reduced but remains a significant holder. |
| Excessive M&A / empire building | NO | Explicitly pivoted away from acquisitions. Only small tuck-ins (BeatBox). |
| Overpromising on timelines | MILD | China reigniting growth has been a rolling promise since Q3 2024 with limited delivery. |
| Compensation concerns | LOW | Ownership culture emphasized. No egregious packages flagged. |
| Regulatory / legal risk | LOW | Limited tariff exposure (98% locally produced). No major litigation flagged. |
| Excessive reliance on external excuses | MILD | Weather, consumer sentiment, La Nina, calendar effects cited frequently. Often legitimate, but frequency raises questions about volume trajectory control. |
No major red flags. Two mild flags: (1) China turnaround has been promised since Q3 2024 with limited
delivery -- management admitted the business "has far more potential than we delivered"; and (2) weather,
La Nina, and calendar effects cited frequently as volume excuses. Neither rises to a serious concern given
the overall financial delivery and transparent communication.
Concerns and deductions (why not 8 or higher)
Persistent Global Volume Declines
Two consecutive years of global volume decline (-1.5% FY2024, -2.5% FY2025). While management
has offset this with pricing and mix, volume is the lifeblood of a consumer staples business.
The "weather" excuse was used repeatedly across 2025 -- by Q3/Q4 it was becoming tired.
Management has not been able to reverse this despite multiple quarters of "improving momentum"
language.
China Execution Gap
Underperformed the industry in China for 6+ consecutive quarters. Revenue declined ~16% in
Q3 2024, ~6% in Q2 2025, low-teens in FY2025. Management acknowledged the business "has far
more potential than we delivered." The on-trade to off-trade channel shift caught them
flat-footed. This is the biggest execution miss of the Doukeris tenure.
Organic EBITDA Growth Deceleration
Quarterly organic EBITDA growth: Q1 2025 +$392M, Q2 +$341M, Q3 +$177M, Q4 +$116M. Clear
deceleration through 2025. FY2025 organic growth of 4.9% just barely inside the low end of
the 4-8% range. This suggests the productivity and pricing levers may be reaching their
limits without volume recovery.
Bud Light Brand Not Directly Addressed
Management has successfully pivoted the US portfolio, but the Bud Light brand -- still a
massive volume base -- has been left to quietly bleed. This is pragmatic but not without
risk if replacement brands hit headwinds. The strategy is to manage around the problem
rather than fix it directly.
Score rationale
7/10. Michel Doukeris has proven to be a disciplined, strategic operator who
inherited a leveraged, acquisition-dependent company and is successfully transforming it into
an organic growth compounder. The financial delivery has been remarkably consistent -- 13+
quarters of EBITDA within or above the 4-8% range, 220bps of margin expansion in two years,
a step-change in FCF, and deleveraging to sub-3x. The BEES digital platform ($53B GMV, 75%
digitized) is a genuine moat-builder.
Why not higher (8-10): (1) persistent global volume declines that management has not been able to reverse despite multiple quarters of "improving momentum" language; (2) China, where execution has clearly lagged the industry and management has admitted underdelivery; and (3) deceleration of organic EBITDA growth through 2025, suggesting the productivity/pricing levers may be reaching limits without volume recovery.
What would move this to 8: Demonstrated volume stabilization or growth globally, and a credible China turnaround showing sequential improvement against industry benchmarks. The foundation is strong, the strategy is coherent, and communication is best-in-class for the sector -- but execution on the top line (units) needs to catch up.
Why not higher (8-10): (1) persistent global volume declines that management has not been able to reverse despite multiple quarters of "improving momentum" language; (2) China, where execution has clearly lagged the industry and management has admitted underdelivery; and (3) deceleration of organic EBITDA growth through 2025, suggesting the productivity/pricing levers may be reaching limits without volume recovery.
What would move this to 8: Demonstrated volume stabilization or growth globally, and a credible China turnaround showing sequential improvement against industry benchmarks. The foundation is strong, the strategy is coherent, and communication is best-in-class for the sector -- but execution on the top line (units) needs to catch up.
Data sourced from Daloopa (company_id: 52567) and earnings call transcripts Q3 2024 through Q4 2025.